Onodera S, Inaba R, Sato I, Endo K, Suzuki T
Tohoku J Exp Med. 1976 Nov;120(3):269-75. doi: 10.1620/tjem.120.269.
A patient with multiple myeloma who has an IgG-IM-component in serum reacting with both kappa and lambda light chains in immunoelectrophoresis is presented. The possibility of "hybrid molecule (H2LkappaLlambda)" is strongly suspected. The absorption studies of the patient's serum employing anti-kappa and anti-lambda light chains, however, support the view that this apparently single M-component consists of two M-components, IgG 1-kappa and IgG 1-lambda. The reason why these two M-components possessed the identical electrophoretic mobility is unclear. The possibility is high that these two M-components are produced in the same cell.
本文报告了一例多发性骨髓瘤患者,其血清中的IgG免疫球蛋白(IM)成分在免疫电泳中与κ链和λ链均发生反应。强烈怀疑存在“杂交分子(H2LκLλ)”的可能性。然而,使用抗κ链和抗λ链对患者血清进行的吸收研究支持这样一种观点,即这种明显单一的M成分由两种M成分组成,即IgG 1-κ和IgG 1-λ。尚不清楚这两种M成分具有相同电泳迁移率的原因。这两种M成分在同一细胞中产生的可能性很大。